CLINICAL TRIALS PROFILE FOR LIALDA
✉ Email this page to a colleague
All Clinical Trials for LIALDA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00151892 ↗ | Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis | Completed | Shire | Phase 3 | 2005-04-08 | Ulcerative colitis is a disease of the large bowel (colon) and rectum in which the lining of the bowel becomes red and swollen. Over time, patients with this disease may experience acute episodes of diarrhea, rectal bleeding and abdominal pain followed by periods of time without disease symptoms. 5-ASA drugs are a standard treatment for ulcerative colitis. Mesalazine is an experimental drug designed to gradually release 5-ASA into the areas of large bowel associated with ulcerative colitis. This study will test the safety and efficacy of mesalazine in keeping ulcerative colitis in remission. |
| NCT00446849 ↗ | Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) | Completed | Shire | Phase 4 | 2007-05-01 | To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily. |
| NCT00545103 ↗ | Prevention of Recurrence of Diverticulitis | Completed | Shire | Phase 3 | 2007-12-06 | The purpose of this study is to determine whether SPD476 is effective in reducing recurrence of diverticulitis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LIALDA
Condition Name
Clinical Trial Locations for LIALDA
Trials by Country
Clinical Trial Progress for LIALDA
Clinical Trial Phase
Clinical Trial Sponsors for LIALDA
Sponsor Name
